In an attempt to boost its portfolio of generic injectable drugs, pharmaceutical giant Pfizer said it will buy Hospira Inc for $15 billion. Lately, major Pfizer drugs like Lipitor and painkiller Celebrex had been battling loss of patent protection, and competition from cheaper generics. Acquiring Hospira will help them build out their sterile injectables business.